형광 크로마토그래피에 의한 콜레스테롤 측정법의 개발

Development of Total Cholesterol Detection System by Fluorescence Chromatography

  • 오상욱 (전북대학교 사범대학 과학교육학부)
  • Oh, Sang-Wook (Division of Science Education, Institute of Fusion Science, Institute of Science Education, Chonbuk National University)
  • 발행 : 2009.06.30

초록

본 연구에서는 심혈관계 질환의 표지인자인 콜레스테롤의 농도를 새롭게 개발한 형광 크로마토그라피 방법에 의하여 측정 하고자 시도하였다. 개발된 측정 시스템은 크로마토그라피 스트립이 들어 있는 카트리지, 발색제 AEC, 콜레스테롤 옥사데이즈 (Cholesterol Oxidase, CO), 콜레스테롤 에스트라아제(Cholesterol Esterase, CE), 호스래 디쉬페록시다아제 (Horseradish peroxidase, HRP)를 포함하는 효소혼합 수용액, 그리고 형광 판독기로 구성되어 었다. 콜레스테롤 농도 변화에 따른 형광 세기 변화로 얻은 상관계수 r= 0.968로 측정 가능한 농도 범위에서 신뢰할 만한 직선성 관계를 제시하여 주었다. 회복률과 Hitachi 747 검사기기와 비교 테스트에서는 각각 106.5-94%와 상관관계 r = 0.939 (p<0.001)로 비교적 높은 유의성을 보여주었다. 따라서 본 연구에서 개발된 새로운 콜레스테롤 농도 측정법은 빠른 반응 시간 (8분)과 적은 시료량 ($5\;{\mu}l$)을 사용하기에 시료를 실험실로 운반할 필요없이 클리닉에서 측정 가능한 준현장검사 플랫폼형으로 개발되었으며 기존의 고가의 자동화 장비를 사용하는 생화학적 진단방식 대체용으로의 응용이 기대된다.

In this study, we have developed a fluorescence chromatographic assay for the quantification of total cholesterol in serum, which is a well-known risk predictor for cardiovascular diseases. The new assay system consists of a chromatographic strip in a cartridge, enzyme buffer containing cholesterol esterase, cholesterol oxidase, horseradish peroxidase, and color developer AEC, and a laser fluorescence scanner. The correlation coefficient (r) between cholesterol concentration and relative fluorescence units was 0.968 in the new assay, showing a reliable linearity through the tested range of cholesterol. Recovery test and comparability with a Hitachi 747 instrument showed 106.5-94% and r = 0.939 (p<0.001), respectively. The new assay system for cholesterol was developed as a pre-POCT platform conducted in clinics since it is fast (8 min) and uses a small volume of sample ($5\;{\mu}l$), and it may be applied for on-site diagnostics to replace expensive automated biochemical analyzer.

키워드

참고문헌

  1. Nelson, D.L. and Cox M.M.: Lehninger Principles of Biochemistry. 4th Ed., W. H. Freeman, New York, pp. 482-484 (2004)
  2. Highlights of the report of the expert panel on detection, evaluation, and treatment of high blood cholesterol in adults, National Cholesterol Education Program, NIH publication No. 88-2926 (1987)
  3. Bachorik, P.S., and Ross, J.W.: National Cholesterol Education Program recommendations for measurement of lowdensity lipoprotein cholesterol: executive summary. The National Cholesterol Education Program Working Group on Lipoprotein Measurement. Clin. Chem., 41, 1414-1420 (1995)
  4. Kaplan, L.A. and Pesce, A.J.: Clinical Chemistry: Theory, Analysis, and Correlation. 3rd Ed., Mosby Company, St. Louis, Chapter 30 (1996)
  5. Cobbaert, C., Mulder, P.G., Baadenhuijsen, H., Zwang, L., Weykamp, C.W. and Demacker, P.N.: Survey of total error of precipitation and homogeneous HDL-cholesterol methods and simultaneous evaluation of lyophilized saccharose-containing candidate reference materials for HDL-cholesterol. Clin. Chem., 45, 360-370 (1999)
  6. Bishop, M.L., Duben-Engelkirk, J.L., and Fody, E.P.: Clinical Chemistry: Principle, Procedures, Correlations. 5th Ed. Lippincott Williams and Wilkins, Philadelphia, Chapter 12, Lipid and Lipoprotein (2004)
  7. Paek, S.H., Jang, M.R., Mok, R.S., Kim, S.C., and Kim, H.B.: Immunochromatographic membrane strip assay system for a single-class plasma lipoprotein cholesterol, exemplified by high-density lipoprotein cholesterol measurement. Biotechnol Bioeng., 62(2), 145-154 (1999) https://doi.org/10.1002/(SICI)1097-0290(19990120)62:2<145::AID-BIT3>3.0.CO;2-Y
  8. Kumar, H, Kumar, A., Kumari, P., Jyotirmai, S. and Tulsani, N.B.: Immobilization of cholesterol oxidase on Formvar using organic solvents. Biotechnol. Appl. Biochem., 30, 231-233 (1999)
  9. Amundson, D.M. and Zhou M.: Fluorometric method for the enzymatic determination of cholesterol. J. Biochem. Biophys. Methods, 38, 43-52 (1999) https://doi.org/10.1016/S0165-022X(98)00036-0
  10. Kim, BC., Jeong, JH., Jeong, DS,. Choi, EY., Kim, J.H. and Nahm, KB.: Simplified laser fluorescence scanner for proteomics studies and early cancer diagnosis. SPIE Proceedings, 4916, 103-108 (2002) https://doi.org/10.1117/12.482938
  11. Ahn JS, Choi S, Jang SH, Chang HJ, Kim JH, Nahm, KB, Oh SW, and Choi EY.: Development of a point-of-care assay system for high-sensitivity C-reactive protein in whole blood. Clin Chim Acta, 332, 51-59 (2003) https://doi.org/10.1016/S0009-8981(03)00113-X
  12. Law, W.T., Doshi, S., McGeehan, J., McGeehan, S., Gibboni, D., Nikolioukine, Y., Keane, R., Zheng, J., Rao, J. and Ertingshausen, G.: Whole-blood test for total cholesterol by a self-metering, self-timing disposable device with built-in quality control. Clin. Chem., 43(2), 384-389 (1997)
  13. Rifai, N. and Pidker, P.M.: Proposed cardiovascular risk assessment algorithm using high-sensitivity C-reactive protein and lipid screening. Clin. Chem., 47, 28-30 (2001)